Accelerated Approval of New TKI Use in CML Sparks Questions
US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) ...
US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) ...
Catheter ablation is fast becoming one of the safest and most effective treatments for atrial fibrillation (AF) as new technologies ...
WASHINGTON (Reuters) - The U.S. Supreme Court is set on Monday to hear the U.S. Food and Drug Administration's defense ...
TOPLINE:At 1 year, 82% of patients with breast cancer who received a 1-week ultrahypofractionated breast radiotherapy regimen reported no or ...
SAN DIEGO — Groundbreaking studies into leukemia treatments and the effects of glucagon-like peptide 1 (GLP-1) inhibitors on venous thromboembolism ...
TOPLINE:Sotagliflozin, a dual sodium-glucose cotransporter 1 and 2 inhibitor, rapidly improves hemoglobin levels in patients with type 2 diabetes (T2D) ...
TOPLINE:A link between hepatic fat and intrapancreatic fat deposition (IPFD) in young and middle-aged adults without obesity and with low ...
TOPLINE:Individuals with normal body mass index (BMI) measurements may still face an increased risk for colorectal cancer (CRC) if they ...
The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement ...
Older adults who are sensitive to the distress of others are more likely to feel anxious or depressed themselves because ...
Antimicrobial resistance (AMR) is globally recognized as one of the greatest health threats of the 21st century, responsible for 1.27 ...
CHICAGO — A randomized placebo-controlled trial testing a direct oral anticoagulant for the prevention of cognitive decline in patients with ...
OuraSmart rings have built-in sensors that monitor the wearer's heart rate and other health issuesWearable tech – currently dominated by ...
© 2022 NewsHealth.
© 2022 NewsHealth.